There are usually two strategies to target EGFR for GBM treatment: EGFR inhibitors, antibodies, vaccines, chimeric antigen receptor-T (CAR-T) cells, and other therapies to reduce the level of EGFR overexpressing cells. This evidence concerns the gene EGFR and glioblastoma.